BUTABARBITAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Butabarbital, and what generic alternatives are available?
Butabarbital is a drug marketed by Bundy, Wockhardt, Sandoz, Solvay, Teva, Watson Labs, and Whiteworth Town Plsn. and is included in sixteen NDAs.
The generic ingredient in BUTABARBITAL is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
Summary for BUTABARBITAL
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 16 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 1 |
Patent Applications: | 3,578 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BUTABARBITAL at DailyMed |
Recent Clinical Trials for BUTABARBITAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |